Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma

The management of melanoma has evolved due to improved understanding of its molecular drivers. To augment the current understanding of the prevalence, patterns, and associations of mutations in this disease, the results of clinical testing of 699 advanced melanoma patients using a pan-cancer next ge...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Invest Dermatol
Autors principals: Siroy, Alan E., Boland, Genevieve M., Milton, Denái R., Roszik, Jason, Frankian, Silva, Malke, Jared, Haydu, Lauren, Prieto, Victor G., Tetzlaff, Michael, Ivan, Doina, Wang, Wei-Lien, Torres-Cabala, Carlos, Curry, Jonathan, Roy-Chowdhuri, Sinchita, Broaddus, Russell, Rashid, Asif, Stewart, John, Gershenwald, Jeffrey E., Amaria, Rodabe N., Patel, Sapna P., Papadopoulos, Nicholas E., Bedikian, Agop, Hwu, Wen-Jen, Hwu, Patrick, Diab, Adi, Woodman, Scott E., Aldape, Kenneth D., Luthra, Rajyalakshmi, Patel, Keyur P., Shaw, Kenna R., Mills, Gordon B., Mendelsohn, John, Meric-Bernstam, Funda, Kim, Kevin B., Routbort, Mark J., Lazar, Alexander J., Davies, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289407/
https://ncbi.nlm.nih.gov/pubmed/25148578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2014.366
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars